Pamela Williamson, RAC, FRAPS, joins Acer with over 30 years of experience in regulatory affairs, quality assurance and compliance, pharmacovigilance, clinical and product development and manufacturing operations with the biopharmaceutical industry. Prior to joining Acer, Pam was senior vice president of global regulatory affairs and patient safety at Alexion Pharmaceuticals where she was responsible for supporting the development of late stage internal research and development and external business development efforts. During her tenure at Genzyme Corporation, Pam was senior vice president of regulatory affairs and corporate quality systems followed by senior vice president, global head, for regulatory affairs and compliance where she was responsible for optimizing approval timelines and maximizing the value of the international product portfolio and pipeline. Prior to that, she held several positions with Serono and Ares-Serono, where she directed numerous cross-functional, multilevel teams. She led strategic and operational aspects of regulatory affairs, directed finished drug product technology transfer, manufacturing, operations logistics, and materials management. Pam is a member of the board of trustees for the Albany College of Pharmacy and Health Sciences and a member of the Pharmaceutical Research and Manufacturers of America, Biotechnology Industry Organization, Massachusetts Biotechnology Council, Food and Drug Law Institute, Drug Information Association, and Regulatory Affairs Professionals Society (Fellow). She has an MBA from Northeastern University in Boston.
Pamela M. Williamson, RAC, FRAPS